Search research articles
Contact Us
Filters
Showing results (71-80 of 134) with videos related to
Page
of 14
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 9, 2016
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease
Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Blood Advances
|
January 4, 2018
BRAF<sup>V600E</sup> accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia
Yo-Ting Tsai, Aparna Lakshmanan, Amy Lehman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 14, 2016
Erratum to "Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease" [Biol Blood Marrow Transplant 22(2016):658-668]
Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2012
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502
Eyal C Attar, Jeffrey L Johnson, Philip C Amrein, et al.
Cytometry. Part B, Clinical Cytometry
|
May 6, 2017
A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters
Michael Keeney, Brent L Wood, Benjamin D Hedley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2018
Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone
James P Dugan, Bradley M Haverkos, Lynda Villagomez, et al.
Leukemia & Lymphoma
|
September 19, 2017
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia
Leslie A Andritsos, Nicole R Grieselhuber, Mirela Anghelina, et al.
JCI Insight
|
June 20, 2020
LC-FACSeq is a method for detecting rare clones in leukemia
Eileen Y Hu, James S Blachly, Caner Saygin, et al.
Blood
|
April 2, 2020
Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations
Fabienne Lucas, Karylin Larkin, C Thomas Gregory, et al.
The AAPS Journal
|
May 4, 2011
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells
Sneha V Gupta, Ellen J Sass, Melanie E Davis, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 134) with videos related to
Sort By:
Page
of 14
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 9, 2016
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease
Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Blood Advances
|
January 4, 2018
BRAF<sup>V600E</sup> accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia
Yo-Ting Tsai, Aparna Lakshmanan, Amy Lehman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 14, 2016
Erratum to "Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease" [Biol Blood Marrow Transplant 22(2016):658-668]
Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2012
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502
Eyal C Attar, Jeffrey L Johnson, Philip C Amrein, et al.
Cytometry. Part B, Clinical Cytometry
|
May 6, 2017
A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters
Michael Keeney, Brent L Wood, Benjamin D Hedley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 11, 2018
Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone
James P Dugan, Bradley M Haverkos, Lynda Villagomez, et al.
Leukemia & Lymphoma
|
September 19, 2017
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia
Leslie A Andritsos, Nicole R Grieselhuber, Mirela Anghelina, et al.
JCI Insight
|
June 20, 2020
LC-FACSeq is a method for detecting rare clones in leukemia
Eileen Y Hu, James S Blachly, Caner Saygin, et al.
Blood
|
April 2, 2020
Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations
Fabienne Lucas, Karylin Larkin, C Thomas Gregory, et al.
The AAPS Journal
|
May 4, 2011
Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells
Sneha V Gupta, Ellen J Sass, Melanie E Davis, et al.
Page
of 14